Gilead Sciences | Kostnadene For Salg

Cost Of Sales Endring Dato
AbbVie USD 4.28B 90M 2023-12
Agios Pharmaceuticals USD 586K 47K 2023-12
ALKERMES USD 61.51M 1.75M 2023-09
Alnylam Pharmaceuticals USD 85.86M 1.55M 2023-12
Amgen USD 3.11B 1.31B 2023-12
Eli Lilly USD 1.79B 72.1M 2023-12
Gilead Sciences USD 1.61B 46M 2023-12
GlaxoSmithKline GBP 2.24B 343M 2023-09
Incyte USD 64.05M 9.66M 2023-12
Moderna USD 929M 1.31B 2023-12
Neurocrine Biosciences USD 11.2M 300K 2023-09
Pfizer USD 6.66B 2.24B 2023-12
PTC Therapeutics USD 29.12M 19.62M 2023-12
Regeneron Pharmaceuticals USD 517M 80.6M 2023-12
Sarepta Therapeutics USD 37.03M 2.9M 2023-09
United Therapeutics USD 71M 900K 2023-12
Vertex Pharmaceuticals USD 318.7M 10.1M 2023-09



Gilead Sciences Kostnadene For Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2024.